正月初六上午，从天津自驾而来的许先生一家，在东阿阿胶主力生产厂区"阿胶世界"的探秘长廊里看得 入迷：巨大的不锈钢化皮机取代了传统熬胶的敞口大锅，机械臂在智能化产线上灵活翻飞，视觉检测系 统为每一块即将出厂的阿胶进行"全身体检"。然而，并非所有工序都被机器取代，关键的"擦胶"环节依 旧沿用古法，工人们用浸过纯化水的老粗布将暗淡的胶块擦拭至色如琥珀。 马年春节期间，《证券日报》记者探访了山东聊城东阿县。在这座以阿胶闻名的小城，当地支柱企业东 阿阿胶股份有限公司（以下简称"东阿阿胶"）依托深厚的中医药文化底蕴，将生产线、毛驴繁育基地和 古城景区等打包成独特的工业旅游线路，构建起贯通一、二、三产的工业旅游全产业链。 当不少人厌倦了网红城市和知名景区的拥挤，东阿阿胶提供了一种稀缺的假期体验：远离喧嚣人潮，尽 享被文化包裹的慢生活。工业旅游串起的不仅是景点，更是一种可沉浸、可体验、可带走的年味。 老字号里的"新"年味 参观生产厂区时，每到一个区域都能闻到不同的香气：阿胶枣生产区枣香沁脾，阿胶块生产区药香浓 郁，阿胶糕产区则夹杂着核桃、芝麻的干果香。"我们就是要通过'五觉'的沉浸式体验，让游客感受近 3000年阿胶文化的博 ...

东阿县以"非遗+"模式推动文旅深度融合，构建中国阿胶博物馆、中国毛驴博物馆、毛驴乐园、阿胶世 界体验工厂、东阿阿胶城"三园两馆"文旅体系。数据显示，2025年东阿中医药文化旅游区接待游客达 107万人次，营业收入超1亿元。 东阿县委常委、宣传部部长王辉表示，当地立足非遗资源优势，依托冬至阿胶滋补节等节会，创新表达 形式、丰富体验场景，让非遗从陈列展品变为可看、可玩、可体验的生活元素，让群众在参与中感受文 化温度、共享发展成果。（经济日报记者 王金虎） 结绳花编、秸秆扎刻、面塑等非遗技艺集中亮相，匠人们指尖翻飞，一件件精巧作品跃然眼前。面塑艺 人任玉霞现场创作骏马造型面塑，为马年新春增添吉祥意趣，引得孩子们驻足欢呼。 作为大集亮点，阿胶定制摊位将国家级非物质文化遗产——东阿阿胶制作技艺与个性化定制深度融 合。"游客可按需定制专属阿胶礼盒，让非遗技艺可感可及、走进日常。"东阿阿胶文旅事业部总经理张 庆伟介绍，阿胶定制让古老技艺从工坊走向大众，在互动体验中彰显中医药文化魅力。 非遗走进日常生活，激活了青年人群的消费热情。"把艾灸贴在穴位上，过十几分钟，自主燃尽后就可 以拿掉……"东艾仙草负责人刘霞的摊位前，不少游客 ...

春节期间，山东聊城市东阿中医药文化旅游区内人头攒动、暖意融融，"非遗年货大集"红红火火，游客 们看花灯、赏非遗、品美食、买年货，沉浸式体验传统年味。 古城街巷间，非遗展演轮番登场、好戏连台。西城门外，醒狮腾挪跳跃、气势昂扬，鼓舞展演鼓点铿 锵、气势如虹，将新春喜庆氛围推向高潮。集市上，熟食、海鲜琳琅满目，驴肉包、糕点香气四溢，各 类年货一应俱全。"这里既有地道美食，又能亲手制作阿胶糕、山楂丸，文化味和参与感都特别强。"带 着家人逛集的市民王琦说。 作为大集亮点，阿胶定制摊位将国家级非物质文化遗产——东阿阿胶制作技艺与个性化定制深度融 合。"游客可按需定制专属阿胶礼盒，让非遗技艺可感可及、走进日常。"东阿阿胶文旅事业部总经理张 庆伟介绍，阿胶定制让古老技艺从工坊走向大众，在互动体验中彰显中医药文化魅力。 非遗走进日常生活，激活了青年人群的消费热情。"把艾灸贴在穴位上，过十几分钟，自主燃尽后就可 以拿掉……"东艾仙草负责人刘霞的摊位前，不少游客在工作人员指导下通过艾灸温经通络、祛湿散 寒。不远处，游客正体验专业医师提供的号脉、推拿等康养服务；年轻游客们身着汉服漫步古城，衣袂 飘飘间，仿佛穿越千年，在青砖黛瓦间，邂 ...

Core Viewpoint - Dong-E E-Jiao is investing 1.485 billion yuan to build a health consumer goods industrial park, supporting its "1238" development strategy aimed at enhancing its dual business model of pharmaceuticals and health consumer products [1][2][3] Group 1: Investment and Strategic Development - The company plans to invest 1.485 billion yuan, with 1.421 billion yuan allocated for fixed assets and 0.64 billion yuan for working capital, to establish a health consumer goods industrial park [2] - The project will focus on the production of health consumer products, including food and health supplements, and will include facilities for quality inspection, e-commerce sorting, and storage [2][3] - The construction site is located in the Economic Development Zone of Dong'e County, Shandong Province, covering an area of 406,800 square meters, with a planned construction period of approximately 22 months [2][3] Group 2: Financial Performance and Shareholder Returns - Dong-E E-Jiao has shown consistent growth in revenue and net profit from 2020 to 2024, with revenue increasing from 3.409 billion yuan in 2020 to 5.921 billion yuan in 2024, and net profit rising from 0.43 billion yuan to 1.557 billion yuan during the same period [4][5] - The company has maintained a high dividend payout ratio, distributing a total of 4.081 billion yuan in dividends over five years, which exceeds its net profit during that period [6][7] - In the first three quarters of 2025, the company reported revenue of 4.766 billion yuan and a net profit of 1.274 billion yuan, reflecting a year-on-year growth of 4.41% and 10.53%, respectively [5][6]

Group 1 - The core point of the article is the decision made by the Board of Directors of Dong'e Ejiao Co., Ltd. to invest 1.485 billion yuan in the construction of a health consumer goods industrial park to support the high-quality development of its health consumer goods business [7][16][22] Group 2 - The Board of Directors meeting was held on February 9, 2026, with all 9 directors present, and the meeting complied with relevant laws and regulations [2][4][5] - The meeting approved several proposals, including adjustments to the members of the Board's specialized committees and the investment project for the health consumer goods industrial park [6][7][10] Group 3 - The investment project will utilize 1.485 billion yuan of the company's own funds, with 1.421 billion yuan allocated for fixed asset investment and 0.64 billion yuan for working capital [16][19] - The project aims to produce health consumer goods such as food and health supplements, and will include facilities for production, warehousing, quality inspection, and e-commerce [18][21] Group 4 - The construction of the industrial park is expected to take approximately 22 months from the start of construction [18] - The investment aligns with the company's "1238" development strategy, which focuses on high-quality development in traditional Chinese medicine and expanding into health consumer goods [21][22] Group 5 - The project is deemed necessary to meet the growing demand for health consumer products and to overcome current production capacity limitations [21][22] - The investment is expected to enhance the company's competitive advantage and support sustainable development without affecting existing business operations [22]

Core Viewpoint - Dong'e Ejiao has announced a significant investment of 1.485 billion yuan to build a health consumer goods industrial park in Shandong Province, marking one of its largest single investments in recent years and a key step in its "pharmaceutical + health consumer goods" dual-drive strategy [2][5]. Investment Details - The project will cover an area of 406,800 square meters, with a construction area of 151,100 square meters [6]. - Out of the total investment of 1.485 billion yuan, 1.421 billion yuan will be allocated to fixed asset investment, while 64 million yuan will be for working capital. The funding will come entirely from the company's own resources, with a construction period of 22 months [8]. Strategic Focus - The new industrial park aims to produce health consumer goods such as medicinal food, health supplements, and functional foods, including products like Ejiao cake, Ejiao dates, and Ejiao powder. It will also feature a comprehensive warehouse and e-commerce center, along with a quality inspection incubation center [8]. - The company has reported a revenue of 4.766 billion yuan for the first three quarters of 2025, a year-on-year increase of 4.41%, and a net profit of 1.274 billion yuan, up 10.53% year-on-year. As of the end of the third quarter of 2025, the company had cash reserves of 5.562 billion yuan [8]. Market Challenges - The company faces significant challenges related to the scarcity of its core raw material, donkey hide, which is crucial for its products. The decreasing availability of this resource poses a risk to the company's growth and expansion plans [9]. - To address this "raw material anxiety," the company is focusing on increasing the utilization and added value of its raw materials by extending into health consumer goods. This strategy includes developing deep-processed products that reduce reliance on single raw materials and enhance overall profit margins [10]. Competitive Landscape - The health consumer goods market is highly competitive, with many established players, making it more complex than the traditional pharmaceutical market where Dong'e Ejiao holds a dominant position. The company recognizes the importance of channel development and research, as indicated by the inclusion of an e-commerce center and a new product incubation center in the new park [10].

Core Viewpoint - China Resources Pharmaceutical (华润医药) announced that its non-wholly owned subsidiary, Dong'e Ejiao (东阿阿胶), has decided to invest in and construct a health consumer goods industrial park, which will enhance its production capabilities and support the growth of its health consumer goods business [1][2]. Group 1: Investment and Construction Details - The health consumer goods industrial park is expected to include manufacturing facilities for health consumer products (such as pharmaceuticals, health foods, and functional foods), along with supporting warehousing, logistics facilities, quality inspection centers, new product incubation centers, and e-commerce sorting and finished product warehouses [1]. - The total area of the health consumer goods industrial park is approximately 406,800 square meters, with a proposed construction area of 151,100 square meters, which will include production facilities for Ejiao cakes, Ejiao dates, and Ejiao powder, as well as comprehensive warehouses and other storage facilities [1]. - The total investment for the project is estimated to be around RMB 1.485 billion, with fixed asset investment amounting to approximately RMB 1.421 billion and working capital of about RMB 64 million [1]. Group 2: Strategic Importance - The investment and construction of the health consumer goods industrial park is a necessary requirement for Dong'e Ejiao to implement its "1238" strategy, aiming to create a model for high-quality development in traditional Chinese medicine [2]. - The project is designed to establish a dual-driven business growth model combining pharmaceuticals and health consumer goods, fostering a second growth curve while addressing the urgent needs for the development of health consumer goods [2]. - The existing industrial park faces limitations in expansion and capacity bottlenecks, which hinder the ability to meet the rapid upgrades and iterations in health consumer goods, making the new construction essential for maintaining competitive advantages [2].

Group 1 - The company Huaren Pharmaceutical (03320) announced that its non-wholly owned subsidiary Dong'e Ejiao (000423.SZ) has decided to invest in and construct a health consumer goods industrial park [1] - The health consumer goods industrial park is expected to include manufacturing facilities for health consumer products (such as pharmaceuticals, health foods, and functional foods), along with supporting warehousing and logistics facilities, quality inspection centers, new product incubation centers, and e-commerce sorting and finished product warehouses [1] - The total area of the health consumer goods industrial park is approximately 406,800 square meters, with a proposed construction area of 151,100 square meters, including production facilities for Ejiao cakes, Ejiao dates, and Ejiao powder, as well as comprehensive warehouses and other storage facilities [1] Group 2 - The investment and construction of the health consumer goods industrial park is a necessary requirement for Dong'e Ejiao to implement its "1238" strategy, aiming to create a model for high-quality development in traditional Chinese medicine and establish a dual-driven business growth model of pharmaceuticals and health consumer goods [2] - The existing industrial park of Dong'e Ejiao faces limitations in expansion area and capacity bottlenecks in major production lines, which cannot meet the rapid upgrading and iteration needs of health consumer products [2] - Building the new facilities will help Dong'e Ejiao establish a core advantage in the health consumer goods sector, with a focus on Ejiao series products, enhancing brand regional recognition, and strengthening core competitiveness [2]

Group 1 - The core viewpoint of the article highlights that 佛慈制药 (Foci Pharmaceutical) is actively expanding its presence in the health product industry by developing various health-related products and plans to launch traditional Chinese medicine health teas in June 2024 [1] - The company has already opened 10 佛慈茶馆 (Foci Tea Houses) to sell health teas and medicinal food products, emphasizing the integration of traditional Chinese medicine culture with modern health concepts [1] - Future plans include the development of high-value health foods, special dietary foods, functional beverages, and derivatives of traditional Chinese medicine, leveraging the company's research and development advantages [1]

Core Viewpoint - The company is actively expanding its presence in the health product industry, focusing on traditional Chinese medicine and health-oriented products [1] Group 1: Product Development - The company has developed various health products, including Ejiao cake, bagged tea, and the "One Tea" series of Han-style tea drinks [1] - Starting from June 2024, the company plans to launch a line of traditional Chinese medicinal health teas [1] - The company has opened 10 tea houses to sell specialty health teas and medicinal food products [1] Group 2: Strategic Focus - The company aims to deeply integrate traditional Chinese medicine culture with modern health concepts [1] - It will leverage its resources in "medicinal food homology" and R&D advantages to develop high-value-added health foods, special dietary foods, functional beverages, and derivatives of traditional Chinese medicine [1] - The company is committed to extending its industrial chain in the health sector [1]